Taiwan - Delayed Quote TWD

Sinphar Pharmaceutical Co.,Ltd. (1734.TW)

35.70 -0.70 (-1.92%)
At close: 1:30 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Zhiwen Li Founder & Chairman -- -- --
Chih-Hsiao Chen Assistant GM, CFO & Spokesperson -- -- --

Sinphar Pharmaceutical Co.,Ltd.

No. 84, Zhongshan Road
Dongshan Township Zhongshan Village
Yilan City, 268
Taiwan
886 0 3958 1101 https://www.sinphar.com.tw
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan, Mainland China, the United States, Vietnam, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Other. It produces anti-cancer pharmaceuticals, such as injections, solid reagents, and hormone reagents; and tablets, soft gel capsules and powder and canned special nutrient products. The company also offers shampoo, body wash, tonic water, lotions, moisturizers, sunscreen lotions, and serums; and pharmaceutical packaging products, such as eye drop bottles, dry canisters, tablet bottles, and various medical grade plastic containers. In addition, it provides plant extracts and functional foods; and OEM services, such as product design, manufacturing, etc. to manufacturers, as well as testing and development of food, drug, and cosmetic products. The company was incorporated in 1977 and is headquartered in Yilan City, Taiwan.

Corporate Governance

Sinphar Pharmaceutical Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Jul 13, 2023
    Ex-Dividend Date

Upcoming Events

Related Tickers